3. Jim Wetta and AstraZeneca plc (ADR) (NYSE:AZN) (2010)
AstraZeneca plc (ADR) (NYSE:AZN) whistle blower Jim Wetta filed a case against the company’s unapproved use of the drug Seroquel. Back in early 2000, the drug was authorized to be used for the treatment of schizophrenia and bipolar depression. However Jim revealed that AstraZeneca plc (ADR) (NYSE:AZN) was using this drug for a wide range of not so serious disorders. This resulted in the drug company paying $520 million to the federal government to resolve civil settlements.
David Smart/Shutterstock.com
Follow Astrazeneca Plc (NYSE:AZN)
Follow Astrazeneca Plc (NYSE:AZN)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
